Mild hyperbarics was demonstrated to reduce Parkinson disease symptoms in just 11 weeks
Mild hyperbaric oxygen is effective in preventing the progression of neurodegenerative diseases
Parkinson’s disease is a neurodegenerative disease and the main hallmark is neuron loss and degeneration. In this 11-week study, mHBOT at 1.3 ATA (3 hours per day, 3 times a week) was able to protect the dopaminergic neurons from further loss and further degeneration. More importantly, they observed positive effects in neuron functions.
Exposure to mild hyperbaric oxygen at 1266–1317 hPa with 35–45% oxygen increases the level of oxygen in the blood, especially the oxygen dissolved in blood plasma, and facilitates oxidative metabolism in the mitochondrial tricarboxylic acid cycle in cells and tissues. Metabolic syndrome, lifestyle-related diseases, and arthritis are inhibited and/or improved when rodents are exposed to mild hyperbaric oxygen.
Link to study :